Home

herida Danubio Fecha roja nejm media espada tiburón Bermad

Products and Services | About NEJM
Products and Services | About NEJM

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Article Metrics | About NEJM
Article Metrics | About NEJM

Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media |  NEJM
Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media | NEJM

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM

Otitis Media | NEJM
Otitis Media | NEJM

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth |  NEJM
Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth | NEJM

Mobile Devices and Health | NEJM
Mobile Devices and Health | NEJM

Amazon.com: NEJM This Week — Audio Summaries : The New England Journal of  Medicine: Libros Audibles y Originales
Amazon.com: NEJM This Week — Audio Summaries : The New England Journal of Medicine: Libros Audibles y Originales

Internal Medicine Board Review - NEJM Knowledge+
Internal Medicine Board Review - NEJM Knowledge+

Tympanostomy Tubes for Recurrent Acute Otitis Media | NEJM Resident 360
Tympanostomy Tubes for Recurrent Acute Otitis Media | NEJM Resident 360

The New England Journal of Medicine y NEJM Group se asociaron con Wolters  Kluwer para ampliar el alcance global de las publicaciones de mayor  relevancia | Business Wire
The New England Journal of Medicine y NEJM Group se asociaron con Wolters Kluwer para ampliar el alcance global de las publicaciones de mayor relevancia | Business Wire

NEJM Group | LinkedIn
NEJM Group | LinkedIn

2 021 NEJM Group U.S. Media Kit
2 021 NEJM Group U.S. Media Kit

Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults |  NEJM
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults | NEJM

Lifting Universal Masking in Schools — Covid-19 Incidence among Students  and Staff | NEJM
Lifting Universal Masking in Schools — Covid-19 Incidence among Students and Staff | NEJM

Institutional Remote Access | About NEJM
Institutional Remote Access | About NEJM

Artificial Intelligence and Machine Learning in Clinical Medicine, 2023 |  NEJM
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023 | NEJM

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 |  NEJM
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 | NEJM

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica | NEJM
Phase 2 Trial of Difelikefalin in Notalgia Paresthetica | NEJM

Julian P Villacastin on Twitter: "Excelente revisión en NEJM sobre las  placas de aterosclerosis. Cómo se rompen y cómo cicatrizan y la importancia  que esto tiene en la enfermedad coronaria. https://t.co/xSdBJlwIN6  https://t.co/4y1bpzxXUR" /
Julian P Villacastin on Twitter: "Excelente revisión en NEJM sobre las placas de aterosclerosis. Cómo se rompen y cómo cicatrizan y la importancia que esto tiene en la enfermedad coronaria. https://t.co/xSdBJlwIN6 https://t.co/4y1bpzxXUR" /

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Migraine | NEJM
Migraine | NEJM

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Humoral Innate Immunity and Acute-Phase Proteins | NEJM
Humoral Innate Immunity and Acute-Phase Proteins | NEJM

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple  Myeloma | NEJM
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma | NEJM